🚀 VC round data is live in beta, check it out!
GuangYuYuan Chinese Valuation Multiples
Discover revenue and EBITDA valuation multiples for GuangYuYuan Chinese and similar public comparables like EyePoint, Pharming, Uniphar, DBV Technologies and more.
GuangYuYuan Chinese Overview
About GuangYuYuan Chinese
GuangYuYuan Chinese Herbal Medicine Co Ltd distributes pharmaceutical products. Its products include far plate turtle age wine bottle, niuhuang qingxin pills, boutique angong niuhuang wan, modified turtle age wine, ding kundan, and many more.
Founded
1996
HQ
Employees
3.1K
Website
Sectors
Financials (FY)
EV
$1B
GuangYuYuan Chinese Financials
GuangYuYuan Chinese reported last fiscal year revenue of $179M and EBITDA of $22M.
In the same fiscal year, GuangYuYuan Chinese generated $132M in gross profit, $22M in EBITDA, and $11M in net income.
Revenue (LTM)
GuangYuYuan Chinese P&L
In the most recent fiscal year, GuangYuYuan Chinese reported revenue of $179M and EBITDA of $22M.
GuangYuYuan Chinese expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $179M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $132M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 74% | XXX | XXX | XXX |
| EBITDA | — | XXX | $22M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 12% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 15% | XXX | XXX | XXX |
| Net Profit | — | XXX | $11M | XXX | XXX | XXX |
| Net Margin | — | XXX | 6% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
GuangYuYuan Chinese Stock Performance
GuangYuYuan Chinese has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
GuangYuYuan Chinese's stock price is $2.54.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | -0.2% | XXX | XXX | XXX | $0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGuangYuYuan Chinese Valuation Multiples
GuangYuYuan Chinese trades at 6.8x EV/Revenue multiple, and 54.4x EV/EBITDA.
EV / Revenue (LTM)
GuangYuYuan Chinese Financial Valuation Multiples
As of April 19, 2026, GuangYuYuan Chinese has market cap of $1B and EV of $1B.
Equity research analysts estimate GuangYuYuan Chinese's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
GuangYuYuan Chinese has a P/E ratio of 114.1x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 6.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 54.4x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 44.5x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 9.2x | XXX | XXX | XXX |
| P/E | — | XXX | 114.1x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 79.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified GuangYuYuan Chinese Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
GuangYuYuan Chinese Margins & Growth Rates
GuangYuYuan Chinese's revenue in the last fiscal year declined by (5%).
GuangYuYuan Chinese's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
GuangYuYuan Chinese Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (5%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (4%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 44% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 7% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 58% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
GuangYuYuan Chinese Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| GuangYuYuan Chinese | XXX | XXX | XXX | XXX | XXX | XXX |
| EyePoint | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Uniphar | XXX | XXX | XXX | XXX | XXX | XXX |
| DBV Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| Kissei Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
GuangYuYuan Chinese M&A Activity
GuangYuYuan Chinese acquired XXX companies to date.
Last acquisition by GuangYuYuan Chinese was on XXXXXXXX, XXXXX. GuangYuYuan Chinese acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by GuangYuYuan Chinese
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialGuangYuYuan Chinese Investment Activity
GuangYuYuan Chinese invested in XXX companies to date.
GuangYuYuan Chinese made its latest investment on XXXXXXXX, XXXXX. GuangYuYuan Chinese invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by GuangYuYuan Chinese
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout GuangYuYuan Chinese
| When was GuangYuYuan Chinese founded? | GuangYuYuan Chinese was founded in 1996. |
| Where is GuangYuYuan Chinese headquartered? | GuangYuYuan Chinese is headquartered in China. |
| How many employees does GuangYuYuan Chinese have? | As of today, GuangYuYuan Chinese has over 3K employees. |
| Is GuangYuYuan Chinese publicly listed? | Yes, GuangYuYuan Chinese is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of GuangYuYuan Chinese? | GuangYuYuan Chinese trades under 600771 ticker. |
| When did GuangYuYuan Chinese go public? | GuangYuYuan Chinese went public in 1996. |
| Who are competitors of GuangYuYuan Chinese? | GuangYuYuan Chinese main competitors are EyePoint, Pharming, Uniphar, DBV Technologies. |
| What is the current market cap of GuangYuYuan Chinese? | GuangYuYuan Chinese's current market cap is $1B. |
| What is the current revenue of GuangYuYuan Chinese? | GuangYuYuan Chinese's last fiscal year revenue is $179M. |
| What is the current EV/Revenue multiple of GuangYuYuan Chinese? | Current revenue multiple of GuangYuYuan Chinese is 6.8x. |
| Is GuangYuYuan Chinese profitable? | No, GuangYuYuan Chinese is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.